Effect of a Food Containing Beta-cryptoxanthin to Lipid Metabolism, Liver Function, Glucose Metabolism and Body Fat.

Not Applicable

• Conditions: /A (healthy adults)

• Registration Number: JPRN-UMIN000036477
• Lead Sponsor: TES Holdings Co., Ltd.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-04-11
• Study Completion: 2019-07-11
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Not provided

Exclusion Criteria

[1]Individuals using medical products. [2]Individuals who are or are under treatment or have a history of hyperlipidemia, and the other serious disorders. [3]Individuals who used a drug to treat in the past 1 month. [4]Individuals who have a history of serious hepatopathy, kidney damage, heart disease, lung disease, or blood disease. [5]Individuals who have a history of digestive organ disease. [6]Individuals whose BMI is over 30. [7]Individuals with serious anemia. [8]Individuals who are sensitive to a test product or other foods, and medical products. [9]Individuals who have a nutritional or exercise guidance by a health care provider. [10]Individuals who are on a diet or have changed an exercise habit in the past 2 months. [11]Individuals who are alcoholism or excessively take alcohol expressed in an amount of alcohol over 60g/day. [12]Individuals whose life style will change during the test period. [13]Individuals who had a habit to ingest foods (ex. health-promoting foods) in the past 3 months or will ingest those foods during the test period. [14]Individuals who have a habit to intake mandarin juice more than 2 times in 1 week. [15]Individuals who had intaken averaged 1 mandarin in 1 week from Oct. 2018 to Mar. 2019. [16]Individuals who regularly intake high beta-cryptoxanthin containing ingredients. [17]Individuals who had a habit to ingest foods (ex. health-promoting foods) which adopt to improve lipid metabolism, liver function, glucose metabolism and body fat in the past 3 months or will ingest those foods during the test period. [18]Individuals who donated blood over 200mL in the past 1 month or over 400mL in the past 3 months. [19]Individuals who are or are possibly pregnant, or are lactating. [20]Individuals who participated in other clinical studies in the past 3 months. [21]Individuals who are or whose family is an employee of a health food company. [22]Individuals judged inappropriate for the study by the principal.

Study & Design

• Study Type: Interventional
• Study Design: Not specified